Health & Medicine Clinical Trial Promotes New Standards for Colorectal Cancer Treatment
| Clinical Trial Promotes New Standards for Colorectal Cancer Treatment |
|
| Monday, October 26, 2009 | |
|
In a review article published this month in The Oncologist, UNC’s Dr. Richard M. Goldberg and a team of colleagues catalogue how the data collected in a single large comparative clinical trial testing combination chemotherapy for metastatic colorectal cancer has been used not only to benefit the patients that enrolled but also patients who subsequently developed the disease. It has also helped to refine the clinical trials process and move forward the potential for individualized therapy for patients. These benefits of this collaboration between patients, physicians across the U.S. and Canada, the National Cancer Institutes of the U.S. and Canada, and two pharmaceutical companies (Pharmacia and sanofi-aventis) are being still being realized five years after the original trial concluded. For full release |